Advances in RNA therapeutics for ocular diseases
Eye Discovery · 2026-12 · 2 (4) · 100072
DOI: 10.1016/j.edisc.2026.100072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eye Discovery, 2026-12. Verfasst von Chi Zhang und 5 weiteren Autor:innen. Die Arbeit nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Eye diseases pose a persistent global health burden. With growing insights into their molecular mechanisms, RNA-based therapeutics have emerged as a promising treatment strategy, offering the capacity for precise, upstream intervention at the transcriptional and post-transcriptional level. Here we systematically review the current landscape and translational trajectory of RNA medicines in ophthalmology. We detail the clinical progress in the application of RNA drugs including small interfering RNA (siRNA), antisense oligonucleotides (ASOs), aptamers, microRNAs (miRNAs), and other emerging modalities in preclinical status. We also highlight the innovative delivery strategies and current challenges relevant to ocular RNA drugs. The eye, with its unique drug delivery advantages and immune-privileged status, represents an attractive target for RNA drug development. By integrating recent advances in chemical modification, nanocarrier engineering, and novel administration routes, this work aims to guide future research and foster innovation within the field. We anticipate that emerging RNA-based therapeutics have the potential to substantially reshape the treatment paradigm for a wide range of eye diseases, offering new solutions to unmet clinical needs.
Förderung
- Key Technologies Research and Development Program
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, C., Liao, X., Kou, H., Wu, Y., Qu, L., & Pan, Q. (2026). Advances in RNA therapeutics for ocular diseases. Eye Discovery, 2(4), 100072. https://doi.org/10.1016/j.edisc.2026.100072
Vancouver
Zhang C, Liao X, Kou H, Wu Y, Qu L, Pan Q. Advances in RNA therapeutics for ocular diseases. Eye Discovery. 2026;2(4):100072. doi:10.1016/j.edisc.2026.100072
BibTeX
@article{Zhang2026,
author = {Zhang, Chi and Liao, Xinyuan and Kou, Haomeng and Wu, Ying and Qu, Liang and Pan, Qian},
title = {Advances in RNA therapeutics for ocular diseases},
journal = {Eye Discovery},
year = {2026},
volume = {2},
number = {4},
pages = {100072},
doi = {10.1016/j.edisc.2026.100072}
}
EUVIMED